Skip to main content
Explore URMC

menu

Connect® MDS/AML Disease Registry

Research Question:
What treatments work best for people with MDS, AML or ICUS?

Basic Study Information

Purpose:
The purpose of the Connect® MDS/AML Disease Registry is to provide unique insights into treatment regimens and sequencing of these regimens as they relate to clinical outcomes of patients with newly diagnosed MDS, ICUS or AML in routine clinical practice and evaluate molecular and cellular markers that may provide further prognostic classification and/or might be predictive of therapy outcomes.

Location: University of Rochester ~ Wilmot Cancer Institute

Study Contact Information

Study Coordinator: Melissa Nifenecker
Phone: (908) 219-0809
Email: connectmdsaml-registry@celgene.com

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search